Creative Commons CC-BY 4.0 Introduction It had been recognized by clinicians that marked leukocytosis without any evidence of infection occasionally occurs in patients with non-hematologic malignancies. Asano et al. first demonstrated the production of human granulopoietic factors by tumor cells from a patient with lung cancer, who was associated with marked leukocytosis, and established the clinical entity of colony-stimulating factor Abstract Although G-CSF-producing tumor is well-known, co-production of IL-8 by such tumor and IL-8-induced neutrophil chemotaxis to tumor tissue have not been recognized. A 65-year-old male was diagnosed with papillary renal cell carcinoma accompanied by marked intratumoral neutrophil infiltration after left radical nephrectomy. At presentation, laboratory tests showed a white blood cell count of 47.8×10 9 /l with 84.1% neutrophils and a high CRP of 18.3 mg/dl. Serum concentrations of G-CSF, IL-6, and IL-8 were elevated to 143 pg/ml, 474 pg/ml, and 1,260 pg/ml, respectively. After the operation, the white cell count and serum concentrations of these cytokines returned to normal levels. Real-time quantitative PCR of the tumor tissue revealed high gene expressions of G-CSF and IL-8, which appeared to be the cause of the leukocytosis and intratumoral neutrophil infiltration.
demonstrated that G-CSF-producing tumors produce not only G-CSF but also interleukin-1 (IL-1) and IL-6, and that IL-1 plays a role as a potent enhancer for the production of G-CSF, IL-6, and IL-1 itself (Suzuki et al. 1991) , (Suzuki et al. 1992) , (Tsuyuoka et al. 1994 ).
Furthermore, Takahashi et al. showed that G-CSF-producing tumors produce IL-8 in addition to these 3 cytokines, and that such tumors are associated with marked intratumoral neutrophil infiltration, presumably due to IL-8 produced by the tumor itself (Takahashi et al. 2007 ). In addition, co-production of IL-1, IL-6, and IL8 in G-CSF-producing tumors appears to be caused by hyperactivation of NF-B because the expression of these 4 cytokine genes is up-regulated by this transcription factor (Takahashi et al. 2007 Laboratory tests on admission (Table 1) showed a WBC count of 47.8×10 9 /l with 84.1% neutrophils, a hemoglobin concentration of 7.7 g/dl, and a platelet count (Table 3) . Then, we calculated the expression levels of each gene per 10,000 copies of abl gene according to the following formula:10,000×2^(CqABL-CqTARGET), assuming PCR amplification efficiency as 2. 
Results

As shown in
